Views & Analysis | Perspectives on pharma industry issues

Digital

Two female silhouettes in a city office overlook the urban landscape below

How female leadership can benefit industry

Day One Strategy’s founding partners Abigail Stuart and Hannah Mann share the benefits female leadership can bring to industry.

Patients

Maintenance: The underexamined half of the GLP-1 story

GLP-1 treatments have historically had an exit problem, as appetite suppression stops when the medication stops.

Oncology

pharmaphorum podcast Episode 276, Irina Babina, Concr

Getting predictive technologies to patients, with Concr

Dr Irina Babina, CEO of oncology R&D platform Concr, discusses how current regulatory frameworks were built for static diagnostics.

R&D

Concept of AI overview of patient in clinical trial

How AI simulation could help de-risk obesity and cardiometab...

AI life sciences models allow researchers to explore different patient populations, protocols, and development strategies before a study starts.

Sales & Marketing

Accelerating growth through strategic investment in healthca...

CEVA FORPATIENTS at Rockingham, UK will offer the healthcare supply chain a new, sustainably designed multi-user site.

Views & Analysis

It’s good to talk, NICE says to pharma industry group

NICE has entered into a new dialogue with industry to highlight the benefits of its early scientific advice service.

Views & Analysis

Nine for 2019 Challenges impacting pharma

Nine for 2019: Opportunities for pharma

In the last Nine for 2019 article, we reflected on the major challenges that are sha

Views & Analysis

Nine for 2019: Challenges impacting pharma

As we move close to 2019’s halfway point, it’s time to reflect on the issues that are shaping the pharmaceutical industry for this year and beyond.

Sales & Marketing

Accelerating growth through strategic investment in healthca...

CEVA FORPATIENTS at Rockingham, UK will offer the healthcare supply chain a new, sustainably designed multi-user site.

Sales & Marketing

The patient communication crisis pharma can no longer ignore

Industry's significant investments in patient engagement are only effective if patients trust the communication enough to answer in the first place.

Digital

How female leadership can benefit industry

Day One Strategy’s founding partners Abigail Stuart and Hannah Mann share the benefits female leadership can bring to industry.

Digital

Pharma brands face golden opportunity to extend supply chain...

People are ready for technology that verifies authenticity and provides helpful information directly from the medicinal product itself.

Market Access

$100 notes in pill bottle on aquamarine background with spilled pills

How new PBM transparency rules will alter drug pricing

The complex drug pricing ecosystem means all stakeholders are scrambling to understand how the new regulations and PBMs’ adjustments will impact them.

Market Access

From first approval to lasting value: What sets successful e...

Approval may validate the science, but it does not secure commercial success. That outcome is determined by the decisions made before launch.

Oncology

Getting predictive technologies to patients, with Concr

Dr Irina Babina, CEO of oncology R&D platform Concr, discusses how current regulatory frameworks were built for static diagnostics.

Oncology

How today’s biotechs are helping us Stand Up To Cancer

In recognition of Stand Up To Cancer Day, a look at next-generation treatments that are on the verge of making it into clinical practice.

Oncology

Bridging the innovation gap: Scalable cell therapies, adapti...

Biotech must build manufacturing and trial models that make cell therapies scalable, accessible & commercially viable.

How female leadership can benefit industry

Maintenance: The underexamined half of the GLP-1 story

Getting predictive technologies to patients, with Concr

How AI simulation could help de-risk obesity and cardiometab...

Accelerating growth through strategic investment in healthca...

It’s good to talk, NICE says to pharma industry group

Nine for 2019: Opportunities for pharma

Nine for 2019: Challenges impacting pharma

Accelerating growth through strategic investment in healthca...

The patient communication crisis pharma can no longer ignore

How female leadership can benefit industry

Pharma brands face golden opportunity to extend supply chain...

How new PBM transparency rules will alter drug pricing

From first approval to lasting value: What sets successful e...

Getting predictive technologies to patients, with Concr

How today’s biotechs are helping us Stand Up To Cancer

Bridging the innovation gap: Scalable cell therapies, adapti...

Maintenance: The underexamined half of the GLP-1 story

Why patient safety doesn't end at approval

Redefining the self-care pathway in the evolving hayfever la...

How AI simulation could help de-risk obesity and cardiometab...

Alzheimer's research is moving toward more selective targets

Changing Faces: Board of Director and Advisory Board hires, ...

AI specialists Enveda and Basecamp rake in the cash

Discover a new era of healthcare panel engagement: Grounded ...

Sales & Marketing

Digital

Market Access

Editor's Picks

Oncology

Patients

R&D

Editor's Picks